| Factor Information | |
|---|---|
| Data ID | 1418 |
| Factor | Fasting hyperglycemia(after matched control) |
| Description | ACHD patients were more likely to have elevated fasting plasma glucose levels (40.4% versus 9.2%). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | biomarkers in adults with CHD |
| p Value | <0.001 |
| Conclusion | ACHD patients were more likely to have elevated triglyceride levels , low high-density lipoprotein levels , and elevated fasting plasma glucose levels , while controls were more likely to be hypertensive . |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 527 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/other/D-TGA/NA/VSD/AVSD/ccTGA/TAPVR/EA/ASD/CACA/EIS/PA, IVS/TA |
| Reference | |
|---|---|
| PMID | 26873680 |
| Year | 2016 |
| Title | Metabolic Syndrome in Adults With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Washington,USA | |
| Method | T-test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ACHD(Treatment) | control(Control) |
| Number | 61 | 41 |
| Age | 40 years | 33 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 61(40.4%) | 41(9.2%) |
